$28.31 -0.01 (-0.04%)

Option Care Health, Inc. Common Stock (OPCH)

Option Care Health, Inc. (OPCH) is a leading provider of home and alternate site infusion services in the United States. The company offers a wide range of infusion, pharmacy, and respiratory therapy services for patients with chronic, acute, and specialty conditions. It primarily serves insurance companies, pharmacy benefit managers, and healthcare providers, supporting patient care outside traditional hospital settings.

🚫 Option Care Health, Inc. Common Stock does not pay dividends

Company News

Option Care Health Announces Financial Results for the Second Quarter Ended June 30, 2025
GlobeNewswire Inc. • Option Care Health • July 30, 2025

Option Care Health reported Q2 2025 financial results with net revenue of $1.42 billion, up 15.4% year-over-year. The company showed resilience in a dynamic marketplace, with adjusted diluted earnings per share of $0.41, up 10.8% from the previous year.

JMP Securities bullish on Option Care Health stock Outperform amid market expansion - Investing.com
Investing.com • Emilio Ghigini • July 16, 2024

JMP Securities initiated coverage on Option Care Health (OPCH) with a Market Outperform rating and a price target of $36, citing the company's extensive national presence, comprehensive range of therapies, and robust commercial infrastructure as key factors for its positive outlook.

Zacks.com featured highlights include J.Jill, Option Care Health and Amphenol
Zacks Investment Research • Zacks Equity Research • June 11, 2024

J.Jill, Option Care Health and Amphenol have been highlighted in this Screen of The Week article.

3 Reasons Palantir Stock Can Double Again in 2024
The Motley Fool • [email protected] (Rick Munarriz) • January 12, 2024

Palantir stock soared 167% last year. It could repeat the feat.

Rare Stock Picks In December 2023 - From 34 Discerning Analysts
Seeking Alpha • SA Rare Stock Picks Monthly • January 4, 2024

Discover rare investment picks for December 2023 that you might have overlooked from analysts who make less-frequent recommendations. Read more here.